HighTower Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$306K Hold
32,567
﹤0.01% 2904
2025
Q1
$177K Buy
32,567
+276
+0.9% +$1.5K ﹤0.01% 3209
2024
Q4
$241K Sell
32,291
-813
-2% -$6.06K ﹤0.01% 3037
2024
Q3
$264K Buy
33,104
+414
+1% +$3.3K ﹤0.01% 2899
2024
Q2
$281K Buy
32,690
+2,000
+7% +$17.2K ﹤0.01% 2753
2024
Q1
$635K Buy
30,690
+683
+2% +$14.1K ﹤0.01% 2101
2023
Q4
$693K Sell
30,007
-222,965
-88% -$5.15M ﹤0.01% 2057
2023
Q3
$2.02M Sell
252,972
-45,832
-15% -$366K ﹤0.01% 1372
2023
Q2
$2.6M Hold
298,804
0.01% 1205
2023
Q1
$878K Hold
298,804
﹤0.01% 1744
2022
Q4
$1.05M Hold
298,804
﹤0.01% 1645
2022
Q3
$2.36M Hold
298,804
0.01% 1136
2022
Q2
$2.35M Hold
298,804
0.01% 1163
2022
Q1
$3.63M Hold
298,804
0.01% 1048
2021
Q4
$3.66M Sell
298,804
-229,624
-43% -$2.81M 0.01% 1053
2021
Q3
$5.51M Hold
528,428
0.01% 780
2021
Q2
$4.75M Sell
528,428
-40
-0% -$360 0.01% 816
2021
Q1
$5.37M Hold
528,468
0.02% 709
2020
Q4
$3.48M Sell
528,468
-1
-0% -$7 0.01% 700
2020
Q3
$2.74M Hold
528,469
0.01% 755
2020
Q2
$4M Hold
528,469
0.02% 580
2020
Q1
$5.39M Buy
528,469
+8
+0% +$82 0.03% 426
2019
Q4
$8.19M Sell
528,461
-13
-0% -$202 0.05% 389
2019
Q3
$9.57M Hold
528,474
0.05% 346
2019
Q2
$8.67M Sell
528,474
-10
-0% -$164 0.05% 361
2019
Q1
$9.46M Buy
528,484
+2,475
+0.5% +$44.3K 0.06% 311
2018
Q4
$9.94M Buy
526,009
+265,445
+102% +$5.02M 0.08% 268
2018
Q3
$9.3M Sell
260,564
-10,000
-4% -$357K 0.07% 308
2018
Q2
$5.63M Buy
+270,564
New +$5.63M 0.04% 455